J&J in talks with Japanese govt and Gates foundation to lock a deal on COVID 19 vaccine J&J is said it plans to start the first human trials of its COVID-19 vaccine on July 22 and could kick off late-stage studies…
FDA publicly shares antibody test performance data from kits as part of validation study These results are among first to come from collaborative effort by FDA, NIH, CDC, BARDA
